A prospective study to examine the effectiveness and safety of neuraminidase inhibitors in volunteers who receive long-term prophylaxis against pandemic influenza: PIPET B
Not Applicable
- Conditions
- Pandemic influenzaInfection - Other infectious diseases
- Registration Number
- ACTRN12608000178347
- Lead Sponsor
- ational Centre in HIV Epidemiology and Clinical Research (NCHECR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. Provision of written informed consent
2. Intention to commence, or already commenced prophylaxis with a neuraminidase inhibitor in the context of a place of employment or profession
It is anticipated that participants in this study who are subsequently clinically diagnosed with pandemic influenza will be enrolled in the Index Case protocol (PIPET-A) with follow-up as specified.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method